Ming-Wei Wang

1.6k total citations
28 papers, 1.0k citations indexed

About

Ming-Wei Wang is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ming-Wei Wang has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ming-Wei Wang's work include Receptor Mechanisms and Signaling (16 papers), Neuropeptides and Animal Physiology (11 papers) and Diabetes Treatment and Management (7 papers). Ming-Wei Wang is often cited by papers focused on Receptor Mechanisms and Signaling (16 papers), Neuropeptides and Animal Physiology (11 papers) and Diabetes Treatment and Management (7 papers). Ming-Wei Wang collaborates with scholars based in China, United States and Australia. Ming-Wei Wang's co-authors include Patrick M. Sexton, Denise Wootten, Raymond C. Stevens, Chris de Graaf, Sebastian G. B. Furness, Arthur Christopoulos, Richard D. Ye, Yi-Lynn Liang, Peishen Zhao and Dehua Yang and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Ming-Wei Wang

26 papers receiving 1.0k citations

Peers

Ming-Wei Wang
Giuseppe Deganutti United Kingdom
Parker W. de Waal United States
James Kean United Kingdom
Chi Shing Sum United States
Daniel J Donnelly United Kingdom
Harini Krishnamurthy United States
Giuseppe Deganutti United Kingdom
Ming-Wei Wang
Citations per year, relative to Ming-Wei Wang Ming-Wei Wang (= 1×) peers Giuseppe Deganutti

Countries citing papers authored by Ming-Wei Wang

Since Specialization
Citations

This map shows the geographic impact of Ming-Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Wei Wang more than expected).

Fields of papers citing papers by Ming-Wei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming-Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Wei Wang. The network helps show where Ming-Wei Wang may publish in the future.

Co-authorship network of co-authors of Ming-Wei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ming-Wei Wang. A scholar is included among the top collaborators of Ming-Wei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming-Wei Wang. Ming-Wei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Wei, Qingtong Zhou, & Ming-Wei Wang. (2025). Current challenges and future perspectives of drug discovery in China. Expert Opinion on Drug Discovery. 20(3). 285–294. 1 indexed citations
2.
Liu, Xiao, et al.. (2025). Structural Insights into the Development of Inhibitors Against Cancer-Specific Mutations of PI3Kα. The Annual Review of Pharmacology and Toxicology. 66(1). 465–485.
3.
Han, Wei, et al.. (2025). gmx_RRCS: A Precision Tool for Detecting Subtle Conformational Dynamics in Molecular Simulations. Journal of Molecular Biology. 437(15). 169129–169129.
4.
Li, Cuixia, Yiran Wu, Wenli Wang, et al.. (2023). Structure-Based Ligand Discovery Targeting the Transmembrane Domain of Frizzled Receptor FZD7. Journal of Medicinal Chemistry. 66(17). 11855–11868. 8 indexed citations
5.
Guo, Yu, Qingtong Zhou, Bin Wei, Ming-Wei Wang, & Suwen Zhao. (2023). GPCRana: A web server for quantitative analysis of GPCR structures. Structure. 31(9). 1132–1142.e2. 1 indexed citations
6.
Yuliantie, Elita, Wijnand J. C. van der Velden, Antao Dai, et al.. (2021). Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptor. Biochemical Pharmacology. 192. 114715–114715. 9 indexed citations
7.
Zhang, Xin, Antao Dai, Matthew J. Belousoff, et al.. (2020). Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide. Journal of Biological Chemistry. 295(28). 9313–9325. 32 indexed citations
8.
Darbalaei, Sanaz, Elita Yuliantie, Antao Dai, et al.. (2020). Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors. Biochemical Pharmacology. 180. 114150–114150. 25 indexed citations
9.
Ma, Shanshan, Qingya Shen, Chunyou Mao, et al.. (2020). Molecular Basis for Hormone Recognition and Activation of Corticotropin-Releasing Factor Receptors. Molecular Cell. 77(3). 669–680.e4. 59 indexed citations
10.
Zhao, Peishen, Yi-Lynn Liang, Matthew J. Belousoff, et al.. (2020). Activation of the GLP-1 receptor by a non-peptidic agonist. Nature. 577(7790). 432–436. 126 indexed citations
11.
Vass, Márton, Albert J. Kooistra, Dehua Yang, et al.. (2018). Chemical Diversity in the G Protein-Coupled Receptor Superfamily. Trends in Pharmacological Sciences. 39(5). 494–512. 63 indexed citations
12.
Pham, Vi, Christopher A. Reynolds, Giuseppe Deganutti, et al.. (2018). Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacy. Biochemical Pharmacology. 150. 214–244. 22 indexed citations
13.
Graaf, Chris de, Gaojie Song, Can Cao, et al.. (2017). Extending the Structural View of Class B GPCRs. Trends in Biochemical Sciences. 42(12). 946–960. 106 indexed citations
14.
Crowther, Gregory J., Michael L. Booker, Min He, et al.. (2014). Cofactor-Independent Phosphoglycerate Mutase from Nematodes Has Limited Druggability, as Revealed by Two High-Throughput Screens. PLoS neglected tropical diseases. 8(1). e2628–e2628. 20 indexed citations
15.
Luo, Xiao, et al.. (2014). The insulinotrophic effect of insulin-like peptide 5 in vitro and in vivo. Biochemical Journal. 466(3). 467–473. 42 indexed citations
16.
Wang, Ming-Wei, Richard D. Ye, & Yi Zhun Zhu. (2013). Pharmacology in China: a brief overview. Trends in Pharmacological Sciences. 34(10). 532–533. 3 indexed citations
17.
Liao, Dan, et al.. (2012). Functional Characterization of Three Mouse Formyl Peptide Receptors. Molecular Pharmacology. 83(2). 389–398. 61 indexed citations
18.
Zhou, Caihong, Meiling Sun, Xin Wang, et al.. (2007). Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1. Biochemical Pharmacology. 74(2). 317–326. 12 indexed citations
19.
Tian, Xiao Yu, Jing Li, Xin Xie, et al.. (2005). Stereospecific Induction of Nuclear Factor-κB Activation by Isochamaejasmin. Molecular Pharmacology. 68(6). 1534–1542. 20 indexed citations
20.
Nanamori, Masakatsu, et al.. (2004). A Novel Nonpeptide Ligand for Formyl Peptide Receptor-Like 1. Molecular Pharmacology. 66(5). 1213–1222. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026